| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/28/2004 | EP1413353A1 Chemical array linking layers |
| 04/28/2004 | EP1413299A2 Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function |
| 04/28/2004 | EP1412758A2 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412755A2 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems |
| 04/28/2004 | EP1412754A1 Diagnostic methods and agents |
| 04/28/2004 | EP1412752A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412746A1 HADHs AS MODIFIERS OF THE P21 PATHWAY AND METHODS OF USE |
| 04/28/2004 | EP1412729A2 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system |
| 04/28/2004 | EP1412726A1 Method for detecting at a solid support of complexing or hybridization between at least two basic molecules based on an amplified at the support |
| 04/28/2004 | EP1412537A2 Cardiotoxin molecular toxicology modeling |
| 04/28/2004 | EP1412536A2 Nanoparticle imaging system and method |
| 04/28/2004 | EP1412535A2 Microarrays for cell phenotyping and manipulation |
| 04/28/2004 | EP1412534A2 Method for determining the capacity of fusarium in producing trichothecene toxins |
| 04/28/2004 | EP1412533A2 Method for analysing macromolecules, analysis device and a method for producing an analysis device |
| 04/28/2004 | EP1412532A2 Method to detect splice variants of the calcineurin gene |
| 04/28/2004 | EP1412531A2 Il-4 receptor sequence variation associated with type 1 diabetes |
| 04/28/2004 | EP1412530A2 Ratio-based oligonucleotide probe selection |
| 04/28/2004 | EP1412529A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 04/28/2004 | EP1412528A2 Biosensor and method for detecting macromolecular biopolymers by means of at least one unit for immobilizing macromolecular biopolymers |
| 04/28/2004 | EP1412527A2 Isp-1 and ctb-1 genes and uses thereof |
| 04/28/2004 | EP1412526A2 Enhanced detection and distinction of differential gene expression by enzymatic probe ligation and amplification |
| 04/28/2004 | EP1412525A2 Screening methods and sequences relating thereto |
| 04/28/2004 | EP1412524A2 Detection of specific dinucleotides in dna-samples by fluorescence resonance energy transfer (fret) |
| 04/28/2004 | EP1412523A2 Methods of profiling gene expression, protein or metabolite levels |
| 04/28/2004 | EP1412522A1 Amplifiable probe |
| 04/28/2004 | EP1412521A2 Method for specific, fast detection of threadlike bacteria |
| 04/28/2004 | EP1412519A2 Configurable dynamic three dimensional array |
| 04/28/2004 | EP1412518A2 Sorting and immobilization system for nucleic acids using synthetic binding systems |
| 04/28/2004 | EP1412517A2 Methods, kits and compositions of combination oligomers |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412512A4 Detection of ras mutations |
| 04/28/2004 | EP1412512A2 Detection of ras mutations |
| 04/28/2004 | EP1412509A2 Rna amplification system using plant components in animal cells |
| 04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
| 04/28/2004 | EP1412501A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412494A2 A molecular marker based on the frk2 (fructokinase 2) gene |
| 04/28/2004 | EP1412491A2 Compositions and methods utilizing dna polymerases |
| 04/28/2004 | EP1412487A1 Assay electrodes having immobilized lipid/protein layers and methods of making and using the same |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412484A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 04/28/2004 | EP1412481A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 04/28/2004 | EP1412480A1 Method for preventing the adhesion of particles |
| 04/28/2004 | EP1412479A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 04/28/2004 | EP1412477A2 GPCs AS MODIFIERS OF THE IRRTK AND P21 PATHWAYS AND METHODS OF USE |
| 04/28/2004 | EP1412471A1 Apparatus and method for determining the onset and presence of sepsis conditions |
| 04/28/2004 | EP1412470A2 Automated process for detecting pathogenic organisms in water |
| 04/28/2004 | EP1412413A1 Synthesis and use of organosilica particles |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |
| 04/28/2004 | EP1412386A2 USE OF PEPTIDE FRAGMENTS OF THE CALCIUM CHANNEL $g(A)-1 SUBUNIT, OPTIONALLY COMPRISING MUTATIONS, FOR SCREENING MOLECULES OF THERAPEUTIC INTEREST |
| 04/28/2004 | EP1412381A2 Meningococcus adhesins nada, app and orf40 |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412087A1 Microfabricated two-pin liquid sample dispensing system |
| 04/28/2004 | EP1411982A1 Modulators of p-selectin glycoprotein ligand 1 |
| 04/28/2004 | EP1411975A1 Methylation of histone h4 at arginine 3 |
| 04/28/2004 | EP1411958A1 Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agents |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411823A2 Sensor head for monitoring glucose for use with implantable devices |
| 04/28/2004 | EP1411816A2 Affinity biosensor for monitoring of biological process |
| 04/28/2004 | EP1382688A9 Screening method |
| 04/28/2004 | EP1307539A4 Gene expression profile for kshv infection and methods for treating same |
| 04/28/2004 | EP1299559B1 Methods for identifying inhibitors of the anaphase promoting complex |
| 04/28/2004 | EP1272846A4 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/28/2004 | EP1255559B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/28/2004 | EP1236047B1 Fluorescence correlation spectroscopy to identify compound-target binding |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1129215B1 Ligation assembly and detection of polynucleotides on solid-support |
| 04/28/2004 | EP1068536B1 Improved blood coagulation test |
| 04/28/2004 | EP1017703B1 Pentopyranosyl nucleoside, and production and use of the same |
| 04/28/2004 | EP1012190A4 Eosinophil eotaxin receptor |
| 04/28/2004 | EP1007730A4 METHODS FOR IDENTIFICATION AND ISOLATION OF SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0885309B1 Direct molecular diagnosis of friedreich ataxia |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0777498B1 Conjugates made of metal complexes and oligonucleotides |
| 04/28/2004 | EP0752105B1 Molecular analyzer and method of use |
| 04/28/2004 | EP0555315B1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES |
| 04/28/2004 | CN2613759Y Protein chip |
| 04/28/2004 | CN1492998A Biosensors having improved sample application |
| 04/28/2004 | CN1492936A Method of assaying biological component |
| 04/28/2004 | CN1492924A Genes encoding proteolytic enzymes from aspargilli |
| 04/28/2004 | CN1492875A TTK in diagnosis and as a therapeutic target in cancer |
| 04/28/2004 | CN1492857A Improved compounds for generating chemiluminescence with peroxidase |
| 04/28/2004 | CN1492055A Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use |
| 04/28/2004 | CN1492054A Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use |
| 04/28/2004 | CN1492053A Determination of man-shaped mycoplasma DNA sequence (5) specificity and its use |
| 04/28/2004 | CN1492052A Determination of a section of man-shaped mycoplasma DNA sequence (4) specificity and its use |
| 04/28/2004 | CN1492051A Gene chip combined treating system and relative technology |
| 04/28/2004 | CN1492047A Recmobined plasmid containing c-fos promotor and reporter gene and its producing method and use |
| 04/28/2004 | CN1491954A High efficiency quick degradation genome DNA of light sensitive aromatic heterocyclic compound |
| 04/28/2004 | CN1147592C Process for preparing fluorescent resonance energy transfer type oligonucleotide gene chip |
| 04/28/2004 | CN1147591C Method for producing polyase chain reaction gene chip |
| 04/28/2004 | CN1147590C Method of detecting fluorescent signal of DNA chip based on ratio process |
| 04/28/2004 | CN1147589C Method for detecting flu A-type and B-type in clinic sample |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |